Type II Minocycline-Induced Hyperpigmentation During Long-Term Management of an Epidermal Growth Factor Receptor (EGFR) Inhibitor-Associated Acneiform Eruption.

Dunbar D, Hwang J, Driscoll M.

Open source

DOI
10.7759/cureus.114957
Published
2026-08-21
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.114957,
  title = {Type II Minocycline-Induced Hyperpigmentation During Long-Term Management of an Epidermal Growth Factor Receptor (EGFR) Inhibitor-Associated Acneiform Eruption.},
  author = {Dunbar D and  Hwang J and  Driscoll M.},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.114957},
  url = {https://doi.org/10.7759/cureus.114957}
}

RIS

TY  - JOUR
TI  - Type II Minocycline-Induced Hyperpigmentation During Long-Term Management of an Epidermal Growth Factor Receptor (EGFR) Inhibitor-Associated Acneiform Eruption.
AU  - Dunbar D
AU  -  Hwang J
AU  -  Driscoll M.
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.114957
UR  - https://doi.org/10.7759/cureus.114957
ER  - 

APA

D, D., J, H., & M., D. (2026). Type II Minocycline-Induced Hyperpigmentation During Long-Term Management of an Epidermal Growth Factor Receptor (EGFR) Inhibitor-Associated Acneiform Eruption.. Cureus. https://doi.org/10.7759/cureus.114957

Source records